CPT2 and chronic kidney disease: By starting from the analysis of urinary metabolites associated with chronic kidney allograft injury, we identified a persistent alteration of FA metabolism as a critical element in a carnitine palmitoyltransferase 2–dependent amplification loop contributing to CKD progression.